Trial Profile
Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2013
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Clomifene
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 20 Aug 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Jun 2012 New trial record